First demonstration of simultaneous demultiplexing from 40 Gbit/sinto two channels of 20 Gbit/s by SOA-based all-optical polarisationswitch

Simultaneous demultiplexing from 40 Gbit/s data signal into two channels of 20 Gbit/s using semiconductor optical amplifier (SOA) based all-optical polarisation switch has been demonstrated. Error-free operation was confirmed with no power penalty. This is the first experimental demonstration to prove the full-switching capability of the SOA-based Mach-Zehnder interferometer (MZI) all-optical switch at such a high bit rate regime     

80 Gbit/s wavelength conversion using MQW electroabsorption modulator in delayed-interferometric configuration

Absorption recovery time and cross-phase modulation characteristics of an MQW electroabsorption modulator (EAM) were experimentally analysed. 80 Gbit/s error-free operation of a wavelength converter using the MQW EAM in a delayed-interferometer configuration was demonstrated for the first time.     

Bone marrow relapse in high-risk pediatric patients with acute lymphoblastic leukemia: a comparison of relapse times and initial clinical features of patients on different protocols. Children''s Cancer and Leukemia Study group (CCLSG)

Alpha adrenergic blocker has become the first choice in the medical treatment of benign prostatic hyperplasia (BPH). The efficacy of alpha adrenergic blocker has been suggested to be related to the prostatic tissue components, and to be ineffective in treating the clinical symptoms caused by BPH in some cases. The efficacy and prostate reduction of an anti-androgenic agent, chlormadinone acetate, combined with alpha adrenergic blocker, tamsulosin hydrochloride, were evaluated using 40-BPH patients insufficiently treated with tamsulosin hydrochloride alone. Fifty mg of chlormadinone acetate and 0.2 mg of tamsulosin hydrochloride were administered orally once a day for 16 weeks to patients with a prostate subjective symptoms score, I-PSS, of greater than 13 or a peak flow rate of less than 12 ml/s, even after the treatment with 0.2 mg of tamsulosin hydrochloride alone for more than four weeks. Total I-PSS decreased significantly after four weeks. The total irritative symptom score did not change for 16 weeks, but the total obstructive symptom score decreased significantly, as did the total I-PSS. In objective data, the estimated volume of both total prostate and the transition zone on transrectal ultrasonogram decreased significantly at the end of the treatment, and the peak flow rate decreased significantly after 12 weeks. These findings suggest that the addition of chlormadinone acetate may be a reasonable alternative in the treatment of BPH patients responding insufficiently to tamsulosin hydrochloride alone, and that combination therapy using chlormadinone acetate and tamsulosin hydrochloride may be useful for BPH patients with serious obstructive symptoms.     

Experimental analysis of cross-phase modulation and cross-gain modulation in SOA-injecting CW assist light

Cross-phase modulation (XPM) and cross-gain modulation (XGM) in a semiconductor optical amplifier (SOA) pumped by assist light were experimentally analyzed. A simple analysis technique for evaluating the XPM separately from the XGM was proposed utilizing a polarization-discriminating delayed interferometer. An initial phase deviation and a gain recovery time in SOA with injecting assist light were quantitatively estimated.